about
A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancer.Therapeutic Effects of Repurposed Therapies in Non-Small Cell Lung Cancer: What Is Old Is New Again.Uptake of oxaliplatin and bevacizumab for treatment of node-positive and metastatic colon cancerSurvival of Asian Females With Advanced Lung Cancer in the Era of Tyrosine Kinase Inhibitor Therapy.Impact of oncology drug shortages on patient therapy: unplanned treatment changesClinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.Patterns of care and survival outcomes of palliative radiation for prostate cancer with bone metastases: comparison of ≤5 fractions to ≥10 fractions.Effect of Thoracic Radiotherapy Timing and Fractionation on Survival in Nonmetastatic Small Cell Lung Carcinoma.Influence of Extent of Lymph Node Evaluation on Survival for Pathologically Lymph Node Negative Non-Small Cell Lung Cancer.Treatment of cancer-associated retinopathy with rituximab.Double trouble: a case of concurrent de novo T790M and L858R EGFR mutations in treatment-naive advanced non-small-cell lung cancer.Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial.Exploration of the ASCO and ESMO Value Frameworks for Antineoplastic Drugs.The utilization of MGMT promoter methylation testing in United States hospitals for glioblastoma and its impact on prognosis.Patterns of care and outcomes for glioblastoma in patients with poor performance status.Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013.Impact of socioeconomic status on survival for patients with anal cancer.The time for low-dose computed tomography screening is now: a medical oncologist perspective.Concurrent and apposed hepatocellular carcinoma and small lymphocytic lymphoma/chronic lymphocytic leukemia in a patient with hepatitis C virus.Patterns of care and outcomes of postoperative radiation for low-grade gliomas in United States hospitalsCancer trends among the extreme elderly in the era of cancer screeningExploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare SystemUse of targeted therapies for advanced renal cell carcinoma in the Veterans Health AdministrationA pooled analysis of two phase II trials evaluating metformin plus platinum-based chemotherapy in advanced non-small cell lung cancerA workshop to train medicine faculty to teach clinical reasoningPeer to Peer observation: real-world faculty development
P50
Q34424631-6BF03386-23D8-4C7C-81C3-1818773FB126Q35915762-232BB025-5E9A-4E01-A36B-43BF5C757F45Q36095157-F4E2052E-246C-48A2-A2E0-A7BBBED1D514Q36234452-911B0F7D-C483-434E-955F-414587C69879Q37008542-24F55E8F-DF46-4B0B-ACBB-AA6844C69D8CQ38844281-D216367D-237A-4E2F-BFDE-C12B37333794Q38956789-35187390-7F35-41DF-B758-41162F499424Q39337445-1E2689A0-E727-445B-B0F8-1D6B526D595FQ40289302-10ED627A-654C-42E0-B98E-5A4D107B81B8Q45968740-1F3BEC22-4EFB-43AC-AA78-0A37B607E78AQ45983081-792FD800-A7EF-47D8-B926-B02ABB12813DQ47101079-C0B4C82E-AF19-45CC-BC51-21ACF3271AA7Q47761912-05E0C8CA-FD04-46C3-A9E6-7C5FB8945FF9Q47889780-75A0B62F-B1E1-453A-B480-A9C9AED5717FQ50868147-0A413058-61DA-4405-B370-A8B2C641864BQ52632866-9E46FC15-8D42-449F-AFC1-5ED50F1AE995Q52648399-D3B75F34-62FD-40C1-8AA4-44F44705DDDCQ52661467-541D754B-EB91-4063-8C8F-E5D27A9A991FQ53041764-711FBA7A-D5B6-48E7-B662-01CE13C6DE51Q53352677-FC799932-83B3-44E4-B1E1-380A8B9F1409Q57057070-E3FC42F3-6965-4CC4-98B9-0562440F4A24Q87536782-DE610C8E-E044-4FFC-A8E6-F8BE6339523AQ89881294-F8644C85-CE8E-41FE-8843-433922ED2014Q90179429-2935E81B-557C-406B-AFB1-E0807B104C72Q92132016-400A5320-7BFA-466F-A1BF-77907DD1B28EQ92227579-6AD97AFE-5BE1-4229-8D5A-2FF9A6E9AC8DQ93119910-B8A30E40-38F7-4884-A349-94AAFBA49C1F
P50
description
researcher ORCID: 0000-0001-7230-8432
@en
wetenschapper
@nl
name
Daniel J Becker
@ast
Daniel J Becker
@en
Daniel J Becker
@es
Daniel J Becker
@nl
type
label
Daniel J Becker
@ast
Daniel J Becker
@en
Daniel J Becker
@es
Daniel J Becker
@nl
prefLabel
Daniel J Becker
@ast
Daniel J Becker
@en
Daniel J Becker
@es
Daniel J Becker
@nl
P106
P1153
36122374700
P31
P496
0000-0001-7230-8432